Halozyme Therapeutics Inc. (HALO) Gained 5.22% or 0.79 To Price $15.93 On Thursday

Halozyme Therapeutics Inc. (HALO) gained 5.22% or 0.79 to $15.93. It is near 1.17 million shares traded, which is 142.04% compare to the average total volume 820250. The market cap of HALO is $2.30 billion. The year to date change is 7.52%. The 52 week price range is from $13.24 to $21.48. Price of HALO have changed 8.61% during last week. It have changed -2.45% over last month, -14.61% over last 3 months, -12.03% over last 6 months and -18.86% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HALO is 15.35. It is -3.64% below current price. The 200-day Moving Averages for HALO is 17.49. It is 9.79% above current price. The 52-week High is 21.48. It is 34.84% from the current price. The 52-week Low is 13.24. It is -16.89% from current price.

There are some statistics of HALO. It is has market cap $2.30 billion. The share outstanding is 144.56 million. The average volume is 820250. The revenue is 189.56M. It has 469.21M cash and 202.35M in debt. The gross profit is 182.08M. The percent of top 15 Institution holding is 125.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HALO is 29.34%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HALO is 11.45%.


Share this post